Michel Warny
Overview
Explore the profile of Michel Warny including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
800
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Greenberg R, Marbury T, Foglia G, Warny M
Vaccine
. 2012 Feb;
30(13):2245-9.
PMID: 22306375
Fifty healthy adult (18-55 years) and 48 elderly (≥ 65 years) volunteers were randomized to receive a candidate Clostridium difficile toxoid vaccine (2 μg, 10 μg, or 50 μg) or...
2.
Salnikova M, Joshi S, Rytting J, Warny M, Middaugh C
J Pharm Sci
. 2008 Feb;
97(9):3735-52.
PMID: 18257030
Nosocomial diarrhea and pseudomembranous colitis causing toxins A and B from Clostridium difficile were studied at pH 5-8 and over the temperature range of 10-85 degrees C. The proteins were...
3.
Salnikova M, Joshi S, Rytting J, Warny M, Middaugh C
J Pharm Sci
. 2008 Jan;
97(10):4194-207.
PMID: 18228584
To enhance the physical stability of Clostridium difficile toxoids A and B, screening for stabilizing compounds was performed. The screening of 30 GRAS compounds at various concentrations and in several...
4.
Kukulski F, Ben Yebdri F, Lefebvre J, Warny M, Tessier P, Sevigny J
J Leukoc Biol
. 2007 Feb;
81(5):1269-75.
PMID: 17322022
Extracellular nucleotides are emerging as important inflammatory mediators. Here, we demonstrate that these molecules mediate LPS-induced neutrophil migration in vitro and in vivo. Apyrase, a nucleotide scavenger, reduced the ability...
5.
Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, et al.
Lancet
. 2005 Sep;
366(9491):1079-84.
PMID: 16182895
Background: Toxins A and B are the primary virulence factors of Clostridium difficile. Since 2002, an epidemic of C difficile-associated disease with increased morbidity and mortality has been present in...
6.
Sougioultzis S, Kyne L, Drudy D, Keates S, Maroo S, Pothoulakis C, et al.
Gastroenterology
. 2005 Mar;
128(3):764-70.
PMID: 15765411
Background & Aims: Recurrent C difficile -associated diarrhea (CDAD) is associated with a lack of protective immunity to C difficile toxins. A parenteral C difficile vaccine containing toxoid A and...
7.
Zaman M, Gelrud A, Junaidi O, Regan M, Warny M, Shea J, et al.
Clin Diagn Lab Immunol
. 2004 Sep;
11(5):819-24.
PMID: 15358638
Patients with cystic fibrosis (CF) exhibit an excessive host inflammatory response. The aim of this study was to determine (i) whether interleukin 8 (IL-8) secretion is increased from monocytes from...
8.
Giannasca P, Warny M
Vaccine
. 2004 Mar;
22(7):848-56.
PMID: 15040937
Clostridium difficile, a gram-positive bacterium, is the major cause of hospital-acquired infectious diarrhea and colitis in industrialized nations. C. difficile colonization results from antibiotic administration and subsequent loss of protection...
9.
Aboudola S, Kotloff K, Kyne L, Warny M, Kelly E, Sougioultzis S, et al.
Infect Immun
. 2003 Feb;
71(3):1608-10.
PMID: 12595488
There is a strong association between serum antibody responses to toxin A and protection against Clostridium difficile diarrhea. A parenteral C. difficile toxoid vaccine induced very-high-level responses to anti-toxin A...